Medical management of Cushing's disease: what is the future?

Author: FleseriuMaria, PetersennStephan

Paper Details 
Original Abstract of the Article :
Cushing's disease (CD) is caused by a corticotroph, adrenocorticotropic-hormone (ACTH)-secreting pituitary adenoma resulting in significant morbidity and mortality. Transsphenoidal surgery is the initial treatment of choice in almost all cases. Remission rates for microadenomas are good at 65-90 % (...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443360/

データ提供:米国国立医学図書館(NLM)

Cushing's Disease: Searching for a New Oasis in the Desert of Treatment

Cushing's disease (CD), like a persistent desert drought, can have devastating effects on a patient's health. This article explores the current and future medical treatments for CD, a rare but serious condition caused by a pituitary adenoma that secretes excess adrenocorticotropic hormone (ACTH).

Medical Treatment for CD: A Journey Through the Desert

While transsphenoidal surgery remains the initial treatment of choice, remission rates for CD are variable and recurrence rates are high. The search for effective medical treatments, like finding a reliable source of water in the desert, continues. This article discusses the limitations of existing medical treatments and the potential of new drugs, such as pasireotide, mifepristone, and dopamine agonists, for managing CD.

Health Implications and Application

The development of effective medical treatments for CD, like finding a permanent oasis in the desert, could significantly improve the lives of patients. However, further research is necessary to assess the long-term efficacy and safety of these new drugs and to develop personalized treatment strategies for CD.

Dr.Camel's Conclusion

The journey through the desert of Cushing's disease can be arduous and fraught with challenges. This article offers a glimpse of hope, highlighting the potential of new drugs and treatment strategies to improve the lives of patients. The desert of medical research is vast, and we must continue our quest for more effective and long-lasting treatments for this debilitating condition.

Date :
  1. Date Completed 2013-02-05
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

22674211

DOI: Digital Object Identifier

PMC3443360

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.